UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

British journal of cancer, 2012-05, Vol.106 (11), p.1722-1727

2012

Volltextzugriff (PDF)

potential for fungal biopesticides to reduce malaria transmission under diverse environmental conditions

The Journal of applied ecology, 2015-12, Vol.52 (6), p.1558-1566

2015

Volltextzugriff (PDF)

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil

Journal of men's health (Amsterdam), 2010, Vol.7 (3), p.325-325

2010

Volltextzugriff (PDF)

Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects

International journal of clinical pharmacology and therapeutics, 2006-05, Vol.44 (5), p.216-224

2006

Volltextzugriff (PDF)

The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate

International journal of clinical pharmacology and therapeutics, 1999-09, Vol.37 (9), p.456

1999

Volltextzugriff (PDF)

The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine

European journal of clinical pharmacology, 1999-03, Vol.55 (1), p.57-60

1999

Volltextzugriff (PDF)

Reduced Plasma Nisoldipine Concentrations in Phenytoin‐Treated Patients with Epilepsy

Epilepsia (Copenhagen), 1996-11, Vol.37 (11), p.1107-1110

1996

Volltextzugriff (PDF)

Clinical pharmacokinetics of nisoldipine coat-core

Clinical pharmacokinetics, 1998-09, Vol.35 (3), p.191-208

HEINIG, R

1998

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

European journal of clinical pharmacology, 1997, Vol.51 (6), p.473-480

1997

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of BAY x 7195 aerosol, a new and selective receptor antagonist of cysteinyl‐leukotrienes, in normal volunteers

British journal of clinical pharmacology, 1996-08, Vol.42 (2), p.171-178

1996

Volltextzugriff (PDF)

Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3560-3560

2009

Volltextzugriff (PDF)

Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation

International journal of clinical pharmacology and therapeutics, 1997-08, Vol.35 (8), p.341

1997

Volltextzugriff (PDF)

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil: ISMH World Congress 2010 Abstract 136

Journal of men's health (Amsterdam), 2010-10, Vol.7 (3), p.325-325

2010

Volltextzugriff (PDF)

Phase I study of BAY 73–4506, a multikinase inhibitor, administered for 21 days on/7 days off in patients with advanced solid tumors

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3593-3593

2007

Volltextzugriff (PDF)

Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced solid tumors: Final results of a dose-escalation study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2558-2558

2008

Volltextzugriff (PDF)

1066 COMBINATIONS OF SGC STIMULATORS AND PDE5 INHIBITORS AS NEW TREATMENT OPTION FOR DIFFICULT TO TREAT ED PATIENTS WITH INSUFFICIENT RESPONSE TO PDE5 INHIBITOR THERAPY

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.329-329

2011

Volltextzugriff (PDF)

Pupil Reaction: A Valid Sensitive Clinical Biomarker for 5‐HT1A Compounds

Basic & clinical pharmacology & toxicology, 2005-03, Vol.96 (3), p.246-246

2005

Volltextzugriff (PDF)

Determination of BAY x 7195, a novel leukotriene D 4 antagonist, in human plasma by high-performance liquid chromatography with post-column photo derivatisation and fluorescence detection

Journal of chromatography. Biomedical applications, 1995-05, Vol.667 (1), p.137-147

Heinig, R.

1995

Volltextzugriff (PDF)

Pharmacokinetics, safety and tolerability of the orally administered receptor antagonist of cysteinyl-leukotrienes BAY x 7195 in single-dose escalation studies

International journal of clinical pharmacology and therapeutics, 1995-10, Vol.33 (10), p.573

1995

Volltextzugriff (PDF)

Capillary electrophoresis with laser-induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes

Journal of chromatography. B, Biomedical sciences and applications, 1998-09, Vol.716 (1), p.325-334

1998

Volltextzugriff (PDF)

What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE

Diabetes, obesity & metabolism, 2002-01, Vol.4 (s1), p.19-25

Heinig, Robert E.

2002

Volltextzugriff (PDF)

Effect of gender and age on the pharmacokinetics of repinotan

Clinical drug investigation, 2005, Vol.25 (2), p.125-134

2005

Volltextzugriff (PDF)

Pharmacokinetics of escalating doses of intravenous repinotan in healthy male volunteers

Clinical drug investigation, 2005, Vol.25 (2), p.115-123

2005

Volltextzugriff (PDF)

Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids

Journal of chromatography. B, Biomedical sciences and applications, 2000-05, Vol.741 (2), p.257-269

2000

Volltextzugriff (PDF)

The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease

Dementia and geriatric cognitive disorders, 1998-01, Vol.9 Suppl 2 (Suppl. 2), p.15-19

1998

Volltextzugriff (PDF)

1 – 25 von 361

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(280)

Publikationsform

Sprache

Englisch
(288)
Deutsch
(79)
Dänisch
(3)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(103)
Humans
(101)
Female
(55)
Male
(46)
Adult
(44)
Biological And Medical Sciences
(44)
Medical Sciences
(41)
Physical Sciences
(37)
Technology
(35)
Middle Aged
(32)
Physics
(27)
Animals
(24)
Pharmacology & Pharmacy
(19)
Pharmacology. Drug Treatments
(19)
Aged
(14)
Engineering
(14)
Adolescent
(13)
Physics, Applied
(12)
Radiology, Nuclear Medicine & Medical Imaging
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

potential for fungal biopesticides to reduce malaria transmission under diverse environmental conditions

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil

Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects

The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate

The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine

Reduced Plasma Nisoldipine Concentrations in Phenytoin‐Treated Patients with Epilepsy

Clinical pharmacokinetics of nisoldipine coat-core

Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

Pharmacodynamics and pharmacokinetics of BAY x 7195 aerosol, a new and selective receptor antagonist of cysteinyl‐leukotrienes, in normal volunteers

Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC)

Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil: ISMH World Congress 2010 Abstract 136

Phase I study of BAY 73–4506, a multikinase inhibitor, administered for 21 days on/7 days off in patients with advanced solid tumors

Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced solid tumors: Final results of a dose-escalation study

1066 COMBINATIONS OF SGC STIMULATORS AND PDE5 INHIBITORS AS NEW TREATMENT OPTION FOR DIFFICULT TO TREAT ED PATIENTS WITH INSUFFICIENT RESPONSE TO PDE5 INHIBITOR THERAPY

Pupil Reaction: A Valid Sensitive Clinical Biomarker for 5‐HT1A Compounds

Determination of BAY x 7195, a novel leukotriene D 4 antagonist, in human plasma by high-performance liquid chromatography with post-column photo derivatisation and fluorescence detection

Pharmacokinetics, safety and tolerability of the orally administered receptor antagonist of cysteinyl-leukotrienes BAY x 7195 in single-dose escalation studies

Capillary electrophoresis with laser-induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes

What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE

Effect of gender and age on the pharmacokinetics of repinotan

Pharmacokinetics of escalating doses of intravenous repinotan in healthy male volunteers

Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids

The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease

Suchergebnisse filtern